Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Breast cancer is the second leading cause of death for women worldwide. The
heterogeneity of this disease presents a big challenge in its therapeutic management …
heterogeneity of this disease presents a big challenge in its therapeutic management …
The trend toward more target therapy in pancreatic ductal adenocarcinoma
C Deiana, M Agostini, G Brandi… - Expert Review of …, 2024 - Taylor & Francis
Introduction Despite the considerable progress made in cancer treatment through the
development of target therapies, pancreatic ductal adenocarcinoma (PDAC) continues to …
development of target therapies, pancreatic ductal adenocarcinoma (PDAC) continues to …
Differential value of diffusion kurtosis imaging and intravoxel incoherent motion in benign and malignant solitary pulmonary lesions
L **ang, H Yang, Y Qin, Y Wen, X Liu… - Frontiers in …, 2023 - frontiersin.org
Objective To investigate the diagnostic value of diffusion kurtosis imaging (DKI) and
intravoxel incoherent motion (IVIM) whole-lesion histogram parameters in differentiating …
intravoxel incoherent motion (IVIM) whole-lesion histogram parameters in differentiating …
Selective plant alkaloids as potential inhibitors of PARP in pancreatic cancer-An in silico study
T Agarwal, HP Manivannan, VP Veeraraghavan… - 2023 - nopr.niscpr.res.in
Pancreatic cancer is recognized as the fourth leading cause of death. Treatment cost for
pancreatic cancer remains very high. So, searching for novel plant compounds with potent …
pancreatic cancer remains very high. So, searching for novel plant compounds with potent …